Recursion Pharmaceuticals amasses $121 mln Series C


Salt Lake City-based Recursion Pharmaceuticals, a next-gen biopharma company, has secured $121 million in Series C financing. Baillie Gifford’s flagship investment trust Scottish Mortgage Investment Trust PLC led the round.

Source: Press Release